C07J 41/0083
Substituted in position 11-beta by an optionally substituted phenyl group not further
Official title: {substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings}
C07J41/0083 (Substituted in position 11-beta by an optionally substituted phenyl group not further) appears on 140 US grants and 83 published applications in this corpus.
Search patents in C07J- Granted patents
- 140
- Published applications
- 83
- Assignees
- 40
- Inventors
- 221
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 6 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 9 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 3 |
| 2002 | 8 | 5 |
| 2003 | 6 | 6 |
| 2004 | 5 | 5 |
| 2005 | 2 | 4 |
| 2006 | 3 | 1 |
| 2007 | 3 | 1 |
| 2008 | 1 | 0 |
| 2009 | 2 | 2 |
| 2010 | 2 | 3 |
| 2011 | 1 | 0 |
| 2012 | 4 | 7 |
| 2013 | 2 | 3 |
| 2014 | 1 | 3 |
| 2015 | 9 | 6 |
| 2016 | 0 | 4 |
| 2017 | 5 | 4 |
| 2018 | 2 | 1 |
| 2019 | 2 | 4 |
| 2020 | 4 | 4 |
| 2021 | 5 | 11 |
| 2022 | 1 | 1 |
| 2023 | 2 | 2 |
| 2024 | 1 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Orally active leukemia inhibitory factor (LIF) antagonists for the treatment of cancer29 Sep 2026US 12,747,263 B2Evestra, Inc.
- Farnesoid X receptor modulators6 May 2025US 12,291,549 B2Intercept Pharmaceuticals, Inc.
- Compounds and methods for selective proteolysis of glucocorticoid receptors4 Jun 2024US 11,998,606 B2Board of Regents, The University of Texas System
- Therapeutic agents and methods18 Jul 2023US 11,702,443 B2Pop Test Oncology LLC
- Methods for onapristone synthesis dehydration and deprotection28 Mar 2023US 11,613,555 B2Context Biopharma Inc.
- Farnesoid x receptor modulators11 Dec 2025US 2025/0376488 A1
- Processes of making onapristone and intermediates thereof7 Nov 2024US 2024/0368211 A1Tyligand Bioscience (Shanghai) Limited
- Orally active leukemia inhibitory factor (lif) antagonists for the treatment of cancer18 Apr 2024US 2024/0124515 A1Evestra, Inc.
- Therapeutic agents and methods30 Nov 2023US 2023/0382945 A1Pop Test Oncology LLC
- Inhibitors of glucocorticoid receptor30 Mar 2023US 2023/0096870 A1Oric Pharmaceuticals, Inc.
Most cited
By later US patents
- Novel steroids61US 4,386,085 ARoussell Uclaf · 1983
- 11 .beta.-substituted progesterone analogs47US 4,954,490 AResearch Triangle Institute · 1990
- Steroid derivatives44US 4,447,424 ARoussel Uclaf · 1984
- 3-Keto-19-nor-.DELTA.4,9-steroids39US 4,477,445 ARoussel Uclaf · 1984
- 11.beta.-arylestradienes, their production, and pharmaceutical preparations containing same39US 4,609,651 ASchering Corporation · 1986